Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

0.3664
+0.00742.06%
Volume:578.79K
Turnover:216.26K
Market Cap:6.29M
PE:-0.23
High:0.3929
Open:0.3506
Low:0.3501
Close:0.3590
52wk High:2.75
52wk Low:0.1620
Shares:17.17M
Float Shares:11.69M
Volume Ratio:0.08
T/O Rate:4.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6207
EPS(LYR):-2.1664
ROE:-113.90%
ROA:-60.60%
PB:0.47
PE(LYR):-0.17

Loading ...

Company Profile

Company Name:
Mangoceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
3
Office Location:
17130 N. Dallas Parkway,Suite 240,Dallas,Texas,United States
Zip Code:
75248
Fax:
- -
Introduction:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Directors

Name
Position
Jacob D. Cohen
Chairman and Chief Executive Officer
Alex P. Hamilton
Director
Kenny Myers
Director
Lorraine D'Alessio
Director

Shareholders

Name
Position
Jacob D. Cohen
Chairman and Chief Executive Officer
Eugene M. Johnston
Chief Financial Officer